RCM
TENX icon

RA Capital Management’s Tenax Therapeutics TENX Stock Holding History

RA Capital Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-75
Closed -$4.66M – 27
2016
Q4 		$4.66M Hold
75
– – 0.66% 20
2016
Q3 		$5.53M Hold
75
– – 0.57% 23
2016
Q2 		$6.12M Hold
75
– – 0.85% 23
2016
Q1 		$4.9M Hold
75
– – 0.63% 31
2015
Q4 		$7.84M Sell
75
-8
-10% -$830K 0.78% 28
2015
Q3 		$8.01M Hold
83
– – 1.15% 28
2015
Q2 		$9.85M Hold
83
– – 0.99% 32
2015
Q1 		$8.71M Hold
83
– – 0.86% 27
2014
Q4 		$10.3M Buy
83
+10
+14% +$1.21M 1.1% 23
2014
Q3 		$9.18M Buy
73
+63
+630% +$8.09M 1.09% 23
2014
Q2 		$1.29M Buy
+10
New +$1.54M 0.13% 26

Other funds holding TENX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

RA Capital Management's TENX Position: Q1 2017 in Review

RA Capital Management sold out of Tenax Therapeutics (TENX) in Q1 2017, closing a stake of 75 shares — an estimated $4.66M sold.

RA Capital Management first reported a position in TENX in Q2 2014 and held it in 11 quarters. The position peaked at $10.3M in Q4 2014. 11 funds tracked by Wall St. Rank hold TENX as of Q1 2017.

  • RA Capital Management reported no remaining Tenax Therapeutics position as of Q1 2017 after selling out during the quarter.
  • RA Capital Management sold 75 Tenax Therapeutics shares in Q1 2017, an estimated $4.66M.
  • RA Capital Management first reported a position in Tenax Therapeutics in Q2 2014 and held it in 11 quarters.
  • RA Capital Management's Tenax Therapeutics position peaked at $10.3M in Q4 2014.
  • 11 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2017.

Based on RA Capital Management's 13F filing for Q1 2017, filed 15 May 2017.